Skip to main content
Clinical Trials/NCT06564571
NCT06564571
Recruiting
Not Applicable

Artificial Intelligence in Endoscopic Ultrasound

Orlando Health, Inc.1 site in 1 country310 target enrollmentJanuary 19, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pancreatic Cancer
Sponsor
Orlando Health, Inc.
Enrollment
310
Locations
1
Primary Endpoint
Rate of detection pancreatic abnormalities by AI
Status
Recruiting
Last Updated
11 months ago

Overview

Brief Summary

The objective of the study is to determine if this artificial intelligence system is capable of detecting abnormalities in the pancreas that are identified by an endoscopist at endoscopic ultrasound procedures.

Detailed Description

Endoscopic Ultrasound (EUS) is an equipment where an ultrasound transducer is attached to the tip of the endoscope. When advanced to the stomach the organs outside such as the pancreas and liver can be visualized in great detail. This enables diagnosis of conditions such as pancreatic cancer. However, an endoscopist must undergo training to accurately interpret these ultrasound images. The investigators are in the process of developing an artificial intelligence system that could potentially interpret EUS images. The objective of the study is to determine if this artificial intelligence system is capable of detecting abnormalities in the pancreas that are identified by an endoscopist at endoscopic ultrasound procedures. Such correlation if established will lead to possible development of an artificial intelligence platform that can diagnose pancreatic diseases. Such development will potentially minimize human error and decrease learning curve to gain proficiency in EUS.

Registry
clinicaltrials.gov
Start Date
January 19, 2024
End Date
December 2027
Last Updated
11 months ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age ≥ 18 years
  • Any patient undergoing endoscopic ultrasound examination

Exclusion Criteria

  • Age \< 18 years

Outcomes

Primary Outcomes

Rate of detection pancreatic abnormalities by AI

Time Frame: 1 day

Ability of AI to detect pancreatic abnormalities as identified by an endoscopist during EUS examination of the pancreas.

Secondary Outcomes

  • Rate of detection pancreatic solid mass lesions by AI(1 day)
  • Rate of detection pancreatic cystic lesions by AI(1 day)

Study Sites (1)

Loading locations...

Similar Trials